Not publicly disclosed — Drug Target

All drugs that target Not publicly disclosed — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Small molecule · Unknown — investigational small molecule

Phase 3 pipeline (1)

• UGN-103 · UroGen Pharma Ltd. · Small molecule · Oncology
  UGN-103 is a synthetic, small molecule that targets the urothelial cancer cells.